Live Breaking News & Updates on Microfluidic Labyrinth Technology

 E-Mail
IMAGE: Two large natural killer immune cells are surrounded by their much smaller exosomes on the NK-GO microfluidic chip developed at the University of Michigan.
view more 
Credit: Image courtesy of Yoon-Tae Kang and Zeqi Niu.
Building on the promise of emerging therapies to deploy the body s natural killer immune cells to fight cancer, researchers at the University of Michigan Rogel Cancer Center and U-M College of Engineering have gone one step further.
They ve developed what is believed to be the first systematic way to catch natural killer cells and get them to release cancer-killing packets called exosomes. These nano-scale exosomes are thousands of times smaller than natural killer cells or NK cells for short and thus better able to penetrate cancer cells defenses. ....

United States , Gemma Purcell , Venkateshwarg Keshamouni , Sunitha Nagrath , Nithya Ramnath , Thomas Hadlock , Rishindra Reddy , Sarah Owen , Zeqi Niu , Mina Zeinali , Labyrinth Biotech Inc , National Institute Of Health , Rogel Cancer Center , National Science Foundation , Um College Of Engineering , University Of Michigan , Microfluidic Labyrinth Technology , Um Biointerfaces Institute , University Of Michigan Rogel Cancer Center , Michigan Rogel Cancer Center , Gum College , Yoon Tae Kang , Rogel Cancer , National Institute , Um Biointerfaces , Labyrinth Biotech ,